Roeske
|
IU School of Medicine (IUSM) researcher Roger Roeske has received the second annual Innovator of the Year Award, presented earlier this week during a reception at the IU Emerging Technologies Center in Indianapolis.
Roeske, a professor of biochemistry and molecular biology, was honored for his contributions to the research on age-related disease and particularly for his pioneering research that led to the creation of the drug Plenaxis. The drug offers a promising treatment option for prostate cancer patients and received FDA approval Nov. 25.
He is the first IU researcher to discover the makings for a drug that made it to market and was selected for the honor by IU’s Advanced Research and Technology Institute for his success in transferring an IU technology development into a successful commercial application.
Richard Peterson, an IUSM professor of anatomy and cell biology, received the honor in 2003 for his research in the field of diabetes.
The IU Innovator of the Year Award is made possible by a gift from the Central Indiana Corporate Partnership. The intention of the program is to recognize innovation by IU faculty members whose research results in economic opportunities for Hoosiers.
Related stories:
At 76, Roeske is the ‘father of Plenaxis’
Dad’s Day 5K June 14 to benefit
prostate cancer research
Second race in July to focus on
prostate cancer among black men
|
